We arranged a regional lung cancer meeting with appr 100 participants. We have had talks at national and international meetings, and are PIs on several translational and clinical studies. Currently 17 clinical studies for lung cancer patients are ongoing.
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysis
Mol Oncol, 13 (5), 1235-1248
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery
Mol Oncol, 13 (5), 1166-1179
Immune Cell Composition in Human Non-small Cell Lung Cancer
Front Immunol, 9, 3101